Evolution of lymphovascular space invasion in early-stage endometrial carcinoma: stratification, quantification, and clinical implications: a systematic review
- Hai-Yan Sun 1, Xu Wang 2, Li-Xian Wang 3, Qiu-Man Wang 4, Shan Kang 5
- Hai-Yan Sun 1, Xu Wang 2, Li-Xian Wang 3
- 1Department of Obstetrics and Gynecology, Hebei Medical University, Fourth Hospital, Jiankanglu 12, Shijiazhuang, 050011, China. 13582117716@163.com.
- 2Department of Pathology, Hebei Medical University, Fourth Hospital, Jiankanglu 12, Shijiazhuang, 050011, China.
- 3Department of Gynecology and Obstetrics Ultrasonography, Hebei Medical University, Fourth Hospital, Jiankanglu 12, Shijiazhuang, 050011, China.
- 4Department of Obstetrics and Gynecology, Hebei Medical University, Fourth Hospital, Jiankanglu 12, Shijiazhuang, 050011, China.
- 5Department of Obstetrics and Gynecology, Hebei Medical University, Fourth Hospital, Jiankanglu 12, Shijiazhuang, 050011, China. ksjq62cn@sina.com.
- 0Department of Obstetrics and Gynecology, Hebei Medical University, Fourth Hospital, Jiankanglu 12, Shijiazhuang, 050011, China. 13582117716@163.com.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Lymphovascular space invasion (LVSI) is a key prognostic factor in endometrial cancer (EC). Refined classification and quantification of LVSI are crucial for improving risk stratification and patient management in early-stage EC.
Area Of Science
- Gynecologic Oncology
- Pathology
- Clinical Research
Background
- Endometrial carcinoma (EC) is the most common female genital tract malignancy in the US.
- Lymphovascular space invasion (LVSI) is a critical prognostic factor influencing EC outcomes.
- Understanding LVSI is vital for accurate risk stratification and treatment decisions in early-stage EC.
Purpose Of The Study
- To review the evolving understanding of LVSI in early-stage EC.
- To highlight LVSI's implications for stratification, quantification, and clinical management.
- To synthesize current knowledge on LVSI in endometrial cancer.
Main Methods
- Systematic review adhering to PRISMA guidelines.
- Searched PubMed, Web of Science, and Embase/MEDLINE databases (1985-2024).
- Included peer-reviewed articles reporting multivariable hazard ratios for LVSI in EC.
Main Results
- Included 6 studies with 2,345 patients; 85.7% endometrioid histotype, 75.1% FIGO stage I.
- LVSI was present in 21.5% of cases; 62.4% received adjuvant treatment.
- Literature categorized into stratification, quantification, and guideline development, showing progression to tiered classifications.
Conclusions
- LVSI is a significant risk factor in EC, with refined classification and quantification over time.
- Inconsistencies in LVSI thresholds across guidelines hinder standardization.
- Future multicenter studies and new technologies are needed to improve risk stratification and management.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.

